Med by Cell Press

@MedCellPress

Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.

Joined December 2019

164Following

13KFollowers

Pinned

Med by Cell Press@MedCellPress · Mar 27

We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: linkedin.com/company/med-ce…

MedCellPress's tweet image. We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: linkedin.com/company/med-ce…

1.0K

Pinned

Med by Cell Press@MedCellPress · 2 h

Interested in sharing your research at our Cell Symposium in LA? We're keeping the abstract submission system open for poster and short talk submissions until August 1, 2025. Submit here: hubs.li/Q03yBl7k0 @CellSymposia #CSStemCells25

MedCellPress's tweet image. Interested in sharing your research at our Cell Symposium in LA?
We're keeping the abstract submission system open for poster and short talk submissions until August 1, 2025. Submit here: hubs.li/Q03yBl7k0 @CellSymposia #CSStemCells25

154

Pinned

Med by Cell Press@MedCellPress · May 28

Online Now: Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case study dlvr.it/TL28KY

MedCellPress's tweet card. Albano et al. show how epidural electrical stimulation can be used even in spinal cord injury patient medullary cone involvement to enhance lower limb motor functions. They also demonstrate that...

181

Pinned

Med by Cell Press@MedCellPress · May 24

Online Now: Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality dlvr.it/TKyZR5

267

Med by Cell Press@MedCellPress · Jul 22

Online Now: Microbiota-derived metabolites: Key modulators of cancer immunotherapies dlvr.it/TM3Z8M

MedCellPress's tweet card. Microbiota-derived metabolites shape immune responses and influence the efficacy and toxicity of cancer immunotherapies, including checkpoint inhibitors, CAR-T cells, and allogeneic stem cell...

172

Med by Cell Press@MedCellPress · Jul 17

Final call: Abstracts for Gene and cell-based therapies are due tomorrow Friday, July 18. Submit now for a chance to present your work at this symposium in LA! @CellSymposia #CSStemCells2025 hubs.li/Q03xfzXc0

MedCellPress's tweet image. Final call: Abstracts for Gene and cell-based therapies are due tomorrow Friday, July 18. Submit now for a chance to present your work at this symposium in LA! @CellSymposia #CSStemCells2025
hubs.li/Q03xfzXc0

186

Med by Cell Press@MedCellPress · Jul 15

Looking forward to hearing from @Thomas_Rando @UCLAstemcell, Gordana-Vunjak-Novakovic @GVNlab @Columbia & Juan Carlos Izpisua Belmonte @altos_labs in our session “Aging and rejuvenation” @CellSymposia #CSStemCells2025. Abstracts due: July 18! hubs.li/Q03xf8lp0

MedCellPress's tweet image. Looking forward to hearing from @Thomas_Rando @UCLAstemcell, Gordana-Vunjak-Novakovic @GVNlab @Columbia &amp; Juan Carlos Izpisua Belmonte @altos_labs in our session “Aging and rejuvenation” @CellSymposia #CSStemCells2025. Abstracts due: July 18!
hubs.li/Q03xf8lp0

257

Med by Cell Press@MedCellPress · Jul 11

Online Now: Association of anti-PD-1 therapy with severe radiation-induced oral mucositis: A retrospective cohort study and validation in the CONTINUUM trial dlvr.it/TLsmTs

MedCellPress's tweet card. Zou et al. demonstrate that anti-PD-1 therapy raised the risk of severe radiation-induced oral mucositis (RIOM) in nasopharyngeal carcinoma patients under 45 years, receiving specific induction...

194

Med by Cell Press@MedCellPress · Jul 3

Online Now: Conformational ligand-directed targeting of calcium-dependent receptors in acute trauma dlvr.it/TLjQCv

MedCellPress's tweet card. Major trauma is a leading cause of death worldwide; however, translational targets have not been systematically identified. Pasqualini et al. identify a repertoire of trauma-homing ligand peptides...

224

Med by Cell Press@MedCellPress · Jun 27

Online Now: Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers dlvr.it/TLbnJl

$MedCellPress's tweet card. This phase 1 translational study of plinabulin plus anti-PD-1 antibody after radiation therapy in immune checkpoint inhibitor-relapsed/refractory cancers showed good tolerability and encouraging...$

259

Med by Cell Press@MedCellPress · Jun 24

We were so excited to see the innovative science at @KeystoneSymp's Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies! Access the content now on-demand: hubs.li/Q037RhY10 #KSNeuroDegen25

MedCellPress's tweet image. We were so excited to see the innovative science at @KeystoneSymp's Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies! Access the content now on-demand: hubs.li/Q037RhY10 #KSNeuroDegen25

543

Med by Cell Press@MedCellPress · Jun 24

@MedCellPress Editor’s Choice Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype hubs.li/Q03rDfD70

MedCellPress's tweet image. @MedCellPress Editor’s Choice
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype
hubs.li/Q03rDfD70

216

Med by Cell Press@MedCellPress · Jun 20

Online Now: A phase 3, randomized trial to evaluate lot-to-lot consistency of V116, an adult-specific pneumococcal conjugate vaccine (STRIDE-4) dlvr.it/TLT5yn

MedCellPress's tweet card. Scott et al. conducted a randomized, global trial assessing the manufacturing consistency of three lots of V116 (an adult-specific, 21-valent pneumococcal conjugate vaccine); safety, tolerability,...

198

Med by Cell Press@MedCellPress · Jun 16

We were so excited to see the innovative science at @KeystoneSymp's Vaccinology: Horizons Across Disease, Demography and Technology! Access the content now on-demand: hubs.li/Q0395-lB0 #KSVaccines25

MedCellPress's tweet image. We were so excited to see the innovative science at @KeystoneSymp's Vaccinology: Horizons Across Disease, Demography and Technology! Access the content now on-demand: hubs.li/Q0395-lB0 #KSVaccines25

621

Med by Cell Press@MedCellPress · Jun 10

Online Now: Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer’s disease dlvr.it/TLH6lx

MedCellPress's tweet card. Varma et al. demonstrate that plasma concentrations of GFAP are increased a decade prior to cognitive impairment in AD and associated with pathology. Higher plasma GFAP levels are associated with...

203

Med by Cell Press@MedCellPress · Jun 6

Online Now: Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial dlvr.it/TLChZb

MedCellPress's tweet card. This randomized, double-blind trial evaluated the efficacy of lysergic acid diethylamide (LSD)-assisted therapy in patients with moderate-to-severe major depressive disorder. Results showed greater...

182

Med by Cell Press@MedCellPress · Jun 4

Online Now: Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study dlvr.it/TL9B9S

MedCellPress's tweet card. Chen et al. investigated the efficacy of TTFields plus pembrolizumab and TMZ in newly diagnosed GBM. The triple regimen improved survival and enhanced anti-tumor immunity, especially in patients with...

216

Med by Cell Press@MedCellPress · Jun 3

Online Now: Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis dlvr.it/TL8L7k

371

Med by Cell Press@MedCellPress · May 30

Online Now: Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission dlvr.it/TL4V7l

219

Med by Cell Press@MedCellPress · May 29

Online Now: Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trial dlvr.it/TL33mN

166

Med by Cell Press@MedCellPress · May 27

Online Now: Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy dlvr.it/TL1Nvh

$MedCellPress's tweet card. Chronic inflammatory demyelinating polyneuropathy (CIDP) presents a significant therapeutic challenge. Here, BCMA-targeted CAR-T cell therapy was applied to two patients with refractory CIDP,...$

360